Literature DB >> 19781269

[The expression of galectin-3 and osteopontin in occult metastasis of non-small cell lung cancer].

Yong Liang1, Hui Li, Sheng-cai Hou, Bin Hu, Jin-bai Miao, Tong Li, Bin You, Li-xin Yu, Lei Wang, Qi-rui Chen, Xing Chen.   

Abstract

OBJECTIVE: To study the relationship between expression of galectin-3 (Gal-3) and osteopontin (OPN) in occult metastasis in non-small cell lung cancer.
METHODS: Forty-six patients of non-small cell lung cancer (NSCLC) from January 2006 to October 2007 were selected. There were 28 males and 18 females, aged from 33 to 77 years old. The levels of lung tissues Gal-3 and OPN were detected by RT-PCR, and the levels of blood plasma's were measured by ELISA.
RESULTS: There were 12 patients who had metastasized. In un-metastasis group the Gal-3 and OPN mRNA expression levels were significantly lower than that in metastasis group: mean value were 0.07 +/- 0.17 and 0.17 +/- 0.25 in un-metastasis group, while 0.73 +/- 0.23 and 0.79 +/- 0.24 in metastasis group. Blood plasma levels of Gal-3 (18.8 +/- 7.9) microg/L and OPN (153.5 +/- 63.5) microg/L in NSCLC which were detected from metastasis group were higher than un-metastasis group of (9.2 +/- 5.6) microg/L and (89.2 +/- 24.0) microg/L.
CONCLUSIONS: High serum levels of Gal-3 and OPN and high expression of Gal-3 and OPN mRNA in NSCLC are closely related to the occurrence and metastasis of NSCLC. They may be indexes of evaluating the occult metastasis in NSCLC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19781269

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  4 in total

1.  The prognostic value of osteopontin expression in non-small cell lung cancer: a meta-analysis.

Authors:  Tao Zhang; Dong-Ming Zhang; Da Zhao; Xiao-Ming Hou; Xiao-Jun Liu; Xiao-Ling Ling; Shou-Cheng Ma
Journal:  J Mol Histol       Date:  2014-05-10       Impact factor: 2.611

2.  Galectin-3 and cyclin D1 expression in non-small cell lung cancer.

Authors:  Monika Kosacka; Paweł Piesiak; Aneta Kowal; Marcin Gołecki; Renata Jankowska
Journal:  J Exp Clin Cancer Res       Date:  2011-10-24

Review 3.  The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment.

Authors:  Mohammad Farhad; Annah S Rolig; William L Redmond
Journal:  Oncoimmunology       Date:  2018-02-20       Impact factor: 8.110

4.  [Expression and related factors of Galectin-3 in non-small cell lung cancer].

Authors:  Meiyan Liu; Bing Du; Chunhong Li; Yanbin Zhao; Qingwei Meng; Li Cai
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2013-08-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.